Index by author

01 December 2003; volume 22, issue 6

A

  1. Aalbers, R.

    1. Seebus, E. et al "A 71‐yr-old male with increasing dyspnoea, cough and an intrathoracic mass." European Respiratory Journal 22.6 (2003): 1042-1045. Web. 28 Feb. 2021.

  2. Agusti, C.

    1. Ioanas, M. et al "Hospital-acquired pneumonia: coverage and treatment adequacy of current guidelines." European Respiratory Journal 22.6 (2003): 876-882. Web. 28 Feb. 2021.

  3. Ansari, T.

    1. Gamble, E. et al "Variation of CD8+ T‐lymphocytes around the bronchial internal perimeter in chronic bronchitis." European Respiratory Journal 22.6 (2003): 992-995. Web. 28 Feb. 2021.

  4. Assimakopoulos, T.

    1. Dingli, K. et al "Spectral oscillations of RR intervals in sleep apnoea/hypopnoea syndrome patients." European Respiratory Journal 22.6 (2003): 943-950. Web. 28 Feb. 2021.

  5. Aurora, P.

    1. Gustafsson, P.M., P. Aurora, and A. Lindblad. "Evaluation of ventilation maldistribution as an early indicator of lung disease in children with cystic fibrosis." European Respiratory Journal 22.6 (2003): 972-979. Web. 28 Feb. 2021.

B

  1. Balthazar, A.

    1. Fornazim, M.C. et al "Evaluation of bronchoalveolar cells in pulmonary paracoccidioidomycosis." European Respiratory Journal 22.6 (2003): 895-899. Web. 28 Feb. 2021.

  2. Barnes, M.C.

    1. Cullinan, P. et al "Can early infection explain the sibling effect in adult atopy?." European Respiratory Journal 22.6 (2003): 956-961. Web. 28 Feb. 2021.

  3. Barnes, N.C.

    1. Gamble, E. et al "Variation of CD8+ T‐lymphocytes around the bronchial internal perimeter in chronic bronchitis." European Respiratory Journal 22.6 (2003): 992-995. Web. 28 Feb. 2021.

  4. Barthélémy, J-C.

    1. Roche, F. et al "Predicting sleep apnoea syndrome from heart period: a time-frequency wavelet analysis." European Respiratory Journal 22.6 (2003): 937-942. Web. 28 Feb. 2021.

  5. Bernard, A.

    1. Blomberg, A. et al "Clara cell protein as a biomarker for ozone-induced lung injury in humans." European Respiratory Journal 22.6 (2003): 883-888. Web. 28 Feb. 2021.

  6. Bernsen, R.M.D.

    1. Bernsen, R.M.D., J.C. de Jongste, and J.C. van der Wouden. "Lower risk of atopic disorders in whole cell pertussis-vaccinated children." European Respiratory Journal 22.6 (2003): 962-964. Web. 28 Feb. 2021.

  7. Blomberg, A.

    1. Blomberg, A. et al "Clara cell protein as a biomarker for ozone-induced lung injury in humans." European Respiratory Journal 22.6 (2003): 883-888. Web. 28 Feb. 2021.

  8. Blotta, M.H.S.L.

    1. Fornazim, M.C. et al "Evaluation of bronchoalveolar cells in pulmonary paracoccidioidomycosis." European Respiratory Journal 22.6 (2003): 895-899. Web. 28 Feb. 2021.

  9. Boehler, A.

    1. Boehler, A., and M. Estenne. "Post-transplant bronchiolitis obliterans." European Respiratory Journal 22.6 (2003): 1007-1018. Web. 28 Feb. 2021.

  10. Böhme, S.

    1. Zühlke, I.E. et al "Montelukast attenuates the airway response to hypertonic saline in moderate-to-severe COPD." European Respiratory Journal 22.6 (2003): 926-930. Web. 28 Feb. 2021.

  11. Boonsawat, W.

    1. Calverley, P.M. et al "Maintenance therapy with budesonide and formoterol in chronicobstructive pulmonary disease." European Respiratory Journal 22.6 (2003): 912-919. Web. 28 Feb. 2021.

  12. Bos, A.P.

    1. Dahlem, P. et al "Incidence and short-term outcome of acute lung injury in mechanically ventilated children." European Respiratory Journal 22.6 (2003): 980-985. Web. 28 Feb. 2021.

  13. Burns, W.

    1. Gamble, E. et al "Variation of CD8+ T‐lymphocytes around the bronchial internal perimeter in chronic bronchitis." European Respiratory Journal 22.6 (2003): 992-995. Web. 28 Feb. 2021.

C

  1. Calverley, P.M.

    1. Calverley, P.M. et al "Maintenance therapy with budesonide and formoterol in chronicobstructive pulmonary disease." European Respiratory Journal 22.6 (2003): 912-919. Web. 28 Feb. 2021.

  2. Campana, Á.O.

    1. Godoy, I. et al "Cytokines and dietary energy restriction in stable chronic obstructive pulmonary disease patients." European Respiratory Journal 22.6 (2003): 920-925. Web. 28 Feb. 2021.

  3. Carter, E.

    1. Carter, E.. "Noseclips in children performing spirometry." European Respiratory Journal 22.6 (2003): 1046. Web. 28 Feb. 2021.

  4. Cavalcanti, M.

    1. Ioanas, M. et al "Hospital-acquired pneumonia: coverage and treatment adequacy of current guidelines." European Respiratory Journal 22.6 (2003): 876-882. Web. 28 Feb. 2021.

  5. Cerdá, M.

    1. Mata, M. et al "Oral N‐acetylcysteine reduces bleomycin-induced lung damage and mucin Muc5ac expression in rats." European Respiratory Journal 22.6 (2003): 900-905. Web. 28 Feb. 2021.

  6. Chavasse, R.

    1. Chavasse, R.. "From the Authors." European Respiratory Journal 22.6 (2003): 1046. Web. 28 Feb. 2021.

  7. Cortijo, J.

    1. Mata, M. et al "Oral N‐acetylcysteine reduces bleomycin-induced lung damage and mucin Muc5ac expression in rats." European Respiratory Journal 22.6 (2003): 900-905. Web. 28 Feb. 2021.

  8. Costabel, U.

    1. Costabel, U.. "Idiopathic pulmonary fibrosis: a treatable disease?." European Respiratory Journal 22.6 (2003): 872-873. Web. 28 Feb. 2021.

  9. Costes, F.

    1. Roche, F. et al "Predicting sleep apnoea syndrome from heart period: a time-frequency wavelet analysis." European Respiratory Journal 22.6 (2003): 937-942. Web. 28 Feb. 2021.

  10. Court-Fortune, I.

    1. Roche, F. et al "Predicting sleep apnoea syndrome from heart period: a time-frequency wavelet analysis." European Respiratory Journal 22.6 (2003): 937-942. Web. 28 Feb. 2021.

  11. Cox, G.

    1. Kelly, M.M., F.E. Hargreave, and G. Cox. "A method to preserve sputum for delayed examination." European Respiratory Journal 22.6 (2003): 996-1000. Web. 28 Feb. 2021.

  12. Cryer, A.

    1. Groneberg, D.A. et al "Aspirin-sensitive rhinitis-associated changes in upper airway innervation." European Respiratory Journal 22.6 (2003): 986-991. Web. 28 Feb. 2021.

  13. Cseke, Z.

    1. Calverley, P.M. et al "Maintenance therapy with budesonide and formoterol in chronicobstructive pulmonary disease." European Respiratory Journal 22.6 (2003): 912-919. Web. 28 Feb. 2021.

  14. Cullinan, P.

    1. Cullinan, P. et al "Can early infection explain the sibling effect in adult atopy?." European Respiratory Journal 22.6 (2003): 956-961. Web. 28 Feb. 2021.

D

  1. Dahlem, P.

    1. Dahlem, P. et al "Incidence and short-term outcome of acute lung injury in mechanically ventilated children." European Respiratory Journal 22.6 (2003): 980-985. Web. 28 Feb. 2021.

  2. Dave, J.R.

    1. Cullinan, P. et al "Can early infection explain the sibling effect in adult atopy?." European Respiratory Journal 22.6 (2003): 956-961. Web. 28 Feb. 2021.

  3. de Jong, R.S.

    1. Seebus, E. et al "A 71‐yr-old male with increasing dyspnoea, cough and an intrathoracic mass." European Respiratory Journal 22.6 (2003): 1042-1045. Web. 28 Feb. 2021.

  4. de Jongste, J.C.

    1. Bernsen, R.M.D., J.C. de Jongste, and J.C. van der Wouden. "Lower risk of atopic disorders in whole cell pertussis-vaccinated children." European Respiratory Journal 22.6 (2003): 962-964. Web. 28 Feb. 2021.

  5. De Rose, V.

    1. Gamble, E. et al "Variation of CD8+ T‐lymphocytes around the bronchial internal perimeter in chronic bronchitis." European Respiratory Journal 22.6 (2003): 992-995. Web. 28 Feb. 2021.

  6. Desager, K.

    1. Oostveen, E. et al "The forced oscillation technique in clinical practice: methodology, recommendations and future developments." European Respiratory Journal 22.6 (2003): 1026-1041. Web. 28 Feb. 2021.

  7. Dijkgraaf, M.G.W.

    1. Dahlem, P. et al "Incidence and short-term outcome of acute lung injury in mechanically ventilated children." European Respiratory Journal 22.6 (2003): 980-985. Web. 28 Feb. 2021.

  8. Dingli, K.

    1. Dingli, K. et al "Spectral oscillations of RR intervals in sleep apnoea/hypopnoea syndrome patients." European Respiratory Journal 22.6 (2003): 943-950. Web. 28 Feb. 2021.

  9. Donaldson, G.C.

    1. Donaldson, G.C. et al "Longitudinal changes in the nature, severity and frequency of COPD exacerbations." European Respiratory Journal 22.6 (2003): 931-936. Web. 28 Feb. 2021.

  10. Douglas, N.J.

    1. Dingli, K. et al "Spectral oscillations of RR intervals in sleep apnoea/hypopnoea syndrome patients." European Respiratory Journal 22.6 (2003): 943-950. Web. 28 Feb. 2021.

  11. Dumont, X.

    1. Blomberg, A. et al "Clara cell protein as a biomarker for ozone-induced lung injury in humans." European Respiratory Journal 22.6 (2003): 883-888. Web. 28 Feb. 2021.

  12. Duverney, D.

    1. Roche, F. et al "Predicting sleep apnoea syndrome from heart period: a time-frequency wavelet analysis." European Respiratory Journal 22.6 (2003): 937-942. Web. 28 Feb. 2021.

E

  1. Estenne, M.

    1. Boehler, A., and M. Estenne. "Post-transplant bronchiolitis obliterans." European Respiratory Journal 22.6 (2003): 1007-1018. Web. 28 Feb. 2021.

F

  1. Farré, R.

    1. Oostveen, E. et al "The forced oscillation technique in clinical practice: methodology, recommendations and future developments." European Respiratory Journal 22.6 (2003): 1026-1041. Web. 28 Feb. 2021.

  2. Ferrer, M.

    1. Ioanas, M. et al "Hospital-acquired pneumonia: coverage and treatment adequacy of current guidelines." European Respiratory Journal 22.6 (2003): 876-882. Web. 28 Feb. 2021.

  3. Fietze, I.

    1. Dingli, K. et al "Spectral oscillations of RR intervals in sleep apnoea/hypopnoea syndrome patients." European Respiratory Journal 22.6 (2003): 943-950. Web. 28 Feb. 2021.

  4. Figg, J.K.

    1. Cullinan, P. et al "Can early infection explain the sibling effect in adult atopy?." European Respiratory Journal 22.6 (2003): 956-961. Web. 28 Feb. 2021.

  5. Fischer, A.

    1. Groneberg, D.A. et al "Aspirin-sensitive rhinitis-associated changes in upper airway innervation." European Respiratory Journal 22.6 (2003): 986-991. Web. 28 Feb. 2021.

  6. Folgering, H.T.

    1. Wohlgemuth, M. et al "Face mask spirometry and respiratory pressures in normal subjects." European Respiratory Journal 22.6 (2003): 1001-1006. Web. 28 Feb. 2021.

  7. Fornazim, M.C.

    1. Fornazim, M.C. et al "Evaluation of bronchoalveolar cells in pulmonary paracoccidioidomycosis." European Respiratory Journal 22.6 (2003): 895-899. Web. 28 Feb. 2021.

  8. Forsberg, B.

    1. Blomberg, A. et al "Clara cell protein as a biomarker for ozone-induced lung injury in humans." European Respiratory Journal 22.6 (2003): 883-888. Web. 28 Feb. 2021.

  9. Fujimoto, K.

    1. Gono, H. et al "Evaluation of airway wall thickness and air trapping by HRCT in asymptomatic asthma." European Respiratory Journal 22.6 (2003): 965-971. Web. 28 Feb. 2021.

G

  1. Gamble, E.

    1. Gamble, E. et al "Variation of CD8+ T‐lymphocytes around the bronchial internal perimeter in chronic bronchitis." European Respiratory Journal 22.6 (2003): 992-995. Web. 28 Feb. 2021.

  2. Garcia, C.

    1. Fornazim, M.C. et al "Evaluation of bronchoalveolar cells in pulmonary paracoccidioidomycosis." European Respiratory Journal 22.6 (2003): 895-899. Web. 28 Feb. 2021.

  3. Garet, M.

    1. Roche, F. et al "Predicting sleep apnoea syndrome from heart period: a time-frequency wavelet analysis." European Respiratory Journal 22.6 (2003): 937-942. Web. 28 Feb. 2021.

  4. Gaston, B.

    1. Vaughan, J. et al "Exhaled breath condensate pH is a robust and reproducible assay of airway acidity." European Respiratory Journal 22.6 (2003): 889-894. Web. 28 Feb. 2021.

  5. Geraldo, R.R.C.

    1. Godoy, I. et al "Cytokines and dietary energy restriction in stable chronic obstructive pulmonary disease patients." European Respiratory Journal 22.6 (2003): 920-925. Web. 28 Feb. 2021.

  6. Gibson, G.J.

    1. Loddenkemper, R., G.J. Gibson, and Y. Sibille. "The burden of lung disease in Europe: why a European White Book on lung disease?." European Respiratory Journal 22.6 (2003): 869-69. Web. 28 Feb. 2021.

  7. Godoy, I.

    1. Godoy, I. et al "Cytokines and dietary energy restriction in stable chronic obstructive pulmonary disease patients." European Respiratory Journal 22.6 (2003): 920-925. Web. 28 Feb. 2021.

  8. Gono, H.

    1. Gono, H. et al "Evaluation of airway wall thickness and air trapping by HRCT in asymptomatic asthma." European Respiratory Journal 22.6 (2003): 965-971. Web. 28 Feb. 2021.

  9. Groneberg, D.A.

    1. Groneberg, D.A. et al "Aspirin-sensitive rhinitis-associated changes in upper airway innervation." European Respiratory Journal 22.6 (2003): 986-991. Web. 28 Feb. 2021.

  10. Gustafsson, P.M.

    1. Gustafsson, P.M., P. Aurora, and A. Lindblad. "Evaluation of ventilation maldistribution as an early indicator of lung disease in children with cystic fibrosis." European Respiratory Journal 22.6 (2003): 972-979. Web. 28 Feb. 2021.

H

  1. Hagenbjörk-Gustafsson, A.

    1. Blomberg, A. et al "Clara cell protein as a biomarker for ozone-induced lung injury in humans." European Respiratory Journal 22.6 (2003): 883-888. Web. 28 Feb. 2021.

  2. Hamaker, M.E.

    1. Dahlem, P. et al "Incidence and short-term outcome of acute lung injury in mechanically ventilated children." European Respiratory Journal 22.6 (2003): 980-985. Web. 28 Feb. 2021.

  3. Hamm, H.

    1. Prasse, A. et al "Does interferon‐γ improve pulmonary function in idiopathic pulmonary fibrosis?." European Respiratory Journal 22.6 (2003): 906-911. Web. 28 Feb. 2021.

  4. Hantos, Z.

    1. Oostveen, E. et al "The forced oscillation technique in clinical practice: methodology, recommendations and future developments." European Respiratory Journal 22.6 (2003): 1026-1041. Web. 28 Feb. 2021.

  5. Hargreave, F.E.

    1. Kelly, M.M., F.E. Hargreave, and G. Cox. "A method to preserve sputum for delayed examination." European Respiratory Journal 22.6 (2003): 996-1000. Web. 28 Feb. 2021.

  6. Harris, J.M.

    1. Cullinan, P. et al "Can early infection explain the sibling effect in adult atopy?." European Respiratory Journal 22.6 (2003): 956-961. Web. 28 Feb. 2021.

  7. Helleday, R.

    1. Blomberg, A. et al "Clara cell protein as a biomarker for ozone-induced lung injury in humans." European Respiratory Journal 22.6 (2003): 883-888. Web. 28 Feb. 2021.

  8. Hendriks, J.C.

    1. Wohlgemuth, M. et al "Face mask spirometry and respiratory pressures in normal subjects." European Respiratory Journal 22.6 (2003): 1001-1006. Web. 28 Feb. 2021.

  9. Heppt, W.

    1. Groneberg, D.A. et al "Aspirin-sensitive rhinitis-associated changes in upper airway innervation." European Respiratory Journal 22.6 (2003): 986-991. Web. 28 Feb. 2021.

  10. Hom, S.

    1. Vaughan, J. et al "Exhaled breath condensate pH is a robust and reproducible assay of airway acidity." European Respiratory Journal 22.6 (2003): 889-894. Web. 28 Feb. 2021.

  11. Hunt, J.

    1. Vaughan, J. et al "Exhaled breath condensate pH is a robust and reproducible assay of airway acidity." European Respiratory Journal 22.6 (2003): 889-894. Web. 28 Feb. 2021.

I

  1. Ioanas, M.

    1. Ioanas, M. et al "Hospital-acquired pneumonia: coverage and treatment adequacy of current guidelines." European Respiratory Journal 22.6 (2003): 876-882. Web. 28 Feb. 2021.

J

  1. Jeffery, P.K.

    1. Gamble, E. et al "Variation of CD8+ T‐lymphocytes around the bronchial internal perimeter in chronic bronchitis." European Respiratory Journal 22.6 (2003): 992-995. Web. 28 Feb. 2021.

  2. Jones, M.

    1. Cullinan, P. et al "Can early infection explain the sibling effect in adult atopy?." European Respiratory Journal 22.6 (2003): 956-961. Web. 28 Feb. 2021.

  3. Jörres, R.A.

    1. Zühlke, I.E. et al "Montelukast attenuates the airway response to hypertonic saline in moderate-to-severe COPD." European Respiratory Journal 22.6 (2003): 926-930. Web. 28 Feb. 2021.

K

  1. Kanniess, F.

    1. Zühlke, I.E. et al "Montelukast attenuates the airway response to hypertonic saline in moderate-to-severe COPD." European Respiratory Journal 22.6 (2003): 926-930. Web. 28 Feb. 2021.

  2. Kawakami, S.

    1. Gono, H. et al "Evaluation of airway wall thickness and air trapping by HRCT in asymptomatic asthma." European Respiratory Journal 22.6 (2003): 965-971. Web. 28 Feb. 2021.

  3. Kelly, M.M.

    1. Kelly, M.M., F.E. Hargreave, and G. Cox. "A method to preserve sputum for delayed examination." European Respiratory Journal 22.6 (2003): 996-1000. Web. 28 Feb. 2021.

  4. Kips, J.

    1. Gamble, E. et al "Variation of CD8+ T‐lymphocytes around the bronchial internal perimeter in chronic bronchitis." European Respiratory Journal 22.6 (2003): 992-995. Web. 28 Feb. 2021.

  5. Kubo, K.

    1. Gono, H. et al "Evaluation of airway wall thickness and air trapping by HRCT in asymptomatic asthma." European Respiratory Journal 22.6 (2003): 965-971. Web. 28 Feb. 2021.

  6. Kurz, C.

    1. Prasse, A. et al "Does interferon‐γ improve pulmonary function in idiopathic pulmonary fibrosis?." European Respiratory Journal 22.6 (2003): 906-911. Web. 28 Feb. 2021.

L

  1. Léon-Velarde, F.

    1. Maggiorini, M., and F. Léon-Velarde. "High-altitude pulmonary hypertension: a pathophysiological entity to different diseases." European Respiratory Journal 22.6 (2003): 1019-1025. Web. 28 Feb. 2021.

  2. Lindblad, A.

    1. Gustafsson, P.M., P. Aurora, and A. Lindblad. "Evaluation of ventilation maldistribution as an early indicator of lung disease in children with cystic fibrosis." European Respiratory Journal 22.6 (2003): 972-979. Web. 28 Feb. 2021.

  3. Llombart-Bosch, A.

    1. Mata, M. et al "Oral N‐acetylcysteine reduces bleomycin-induced lung damage and mucin Muc5ac expression in rats." European Respiratory Journal 22.6 (2003): 900-905. Web. 28 Feb. 2021.

  4. Lloyd-Owen, S.J.

    1. Donaldson, G.C. et al "Longitudinal changes in the nature, severity and frequency of COPD exacerbations." European Respiratory Journal 22.6 (2003): 931-936. Web. 28 Feb. 2021.

  5. Loddenkemper, R.

    1. Loddenkemper, R., G.J. Gibson, and Y. Sibille. "The burden of lung disease in Europe: why a European White Book on lung disease?." European Respiratory Journal 22.6 (2003): 869-69. Web. 28 Feb. 2021.

  6. Lorino, H.

    1. Oostveen, E. et al "The forced oscillation technique in clinical practice: methodology, recommendations and future developments." European Respiratory Journal 22.6 (2003): 1026-1041. Web. 28 Feb. 2021.

M

  1. MacLeod, D.

    1. Oostveen, E. et al "The forced oscillation technique in clinical practice: methodology, recommendations and future developments." European Respiratory Journal 22.6 (2003): 1026-1041. Web. 28 Feb. 2021.

  2. Maggiorini, M.

    1. Maggiorini, M., and F. Léon-Velarde. "High-altitude pulmonary hypertension: a pathophysiological entity to different diseases." European Respiratory Journal 22.6 (2003): 1019-1025. Web. 28 Feb. 2021.

  3. Magnussen, H.

    1. Zühlke, I.E. et al "Montelukast attenuates the airway response to hypertonic saline in moderate-to-severe COPD." European Respiratory Journal 22.6 (2003): 926-930. Web. 28 Feb. 2021.

  4. Mamoni, R.L.

    1. Fornazim, M.C. et al "Evaluation of bronchoalveolar cells in pulmonary paracoccidioidomycosis." European Respiratory Journal 22.6 (2003): 895-899. Web. 28 Feb. 2021.

  5. Marchal, F.

    1. Oostveen, E. et al "The forced oscillation technique in clinical practice: methodology, recommendations and future developments." European Respiratory Journal 22.6 (2003): 1026-1041. Web. 28 Feb. 2021.

  6. Martinez-Losa, M.

    1. Mata, M. et al "Oral N‐acetylcysteine reduces bleomycin-induced lung damage and mucin Muc5ac expression in rats." European Respiratory Journal 22.6 (2003): 900-905. Web. 28 Feb. 2021.

  7. Mata, M.

    1. Mata, M. et al "Oral N‐acetylcysteine reduces bleomycin-induced lung damage and mucin Muc5ac expression in rats." European Respiratory Journal 22.6 (2003): 900-905. Web. 28 Feb. 2021.

  8. Mills, P.

    1. Cullinan, P. et al "Can early infection explain the sibling effect in adult atopy?." European Respiratory Journal 22.6 (2003): 956-961. Web. 28 Feb. 2021.

  9. Moffat, S.A.

    1. Cullinan, P. et al "Can early infection explain the sibling effect in adult atopy?." European Respiratory Journal 22.6 (2003): 956-961. Web. 28 Feb. 2021.

  10. Moon, A.M.

    1. Cullinan, P. et al "Can early infection explain the sibling effect in adult atopy?." European Respiratory Journal 22.6 (2003): 956-961. Web. 28 Feb. 2021.

  11. Morcillo, E.J.

    1. Mata, M. et al "Oral N‐acetylcysteine reduces bleomycin-induced lung damage and mucin Muc5ac expression in rats." European Respiratory Journal 22.6 (2003): 900-905. Web. 28 Feb. 2021.

  12. Mudway, I.

    1. Blomberg, A. et al "Clara cell protein as a biomarker for ozone-induced lung injury in humans." European Respiratory Journal 22.6 (2003): 883-888. Web. 28 Feb. 2021.

  13. Müller, K-M.

    1. Prasse, A. et al "Does interferon‐γ improve pulmonary function in idiopathic pulmonary fibrosis?." European Respiratory Journal 22.6 (2003): 906-911. Web. 28 Feb. 2021.

N

  1. Newman Taylor, A.J.

    1. Cullinan, P. et al "Can early infection explain the sibling effect in adult atopy?." European Respiratory Journal 22.6 (2003): 956-961. Web. 28 Feb. 2021.

  2. Ngamtrakulpanit, L.

    1. Vaughan, J. et al "Exhaled breath condensate pH is a robust and reproducible assay of airway acidity." European Respiratory Journal 22.6 (2003): 889-894. Web. 28 Feb. 2021.

  3. Nguyen, T-A.

    1. Vaughan, J. et al "Exhaled breath condensate pH is a robust and reproducible assay of airway acidity." European Respiratory Journal 22.6 (2003): 889-894. Web. 28 Feb. 2021.

  4. Nielsen-Gode, D.

    1. Zühlke, I.E. et al "Montelukast attenuates the airway response to hypertonic saline in moderate-to-severe COPD." European Respiratory Journal 22.6 (2003): 926-930. Web. 28 Feb. 2021.

  5. Nordberg, G.

    1. Blomberg, A. et al "Clara cell protein as a biomarker for ozone-induced lung injury in humans." European Respiratory Journal 22.6 (2003): 883-888. Web. 28 Feb. 2021.

O

  1. Olsson, H.

    1. Calverley, P.M. et al "Maintenance therapy with budesonide and formoterol in chronicobstructive pulmonary disease." European Respiratory Journal 22.6 (2003): 912-919. Web. 28 Feb. 2021.

  2. Oostveen, E.

    1. Oostveen, E. et al "The forced oscillation technique in clinical practice: methodology, recommendations and future developments." European Respiratory Journal 22.6 (2003): 1026-1041. Web. 28 Feb. 2021.

P

  1. Padberg, G.W.

    1. Wohlgemuth, M. et al "Face mask spirometry and respiratory pressures in normal subjects." European Respiratory Journal 22.6 (2003): 1001-1006. Web. 28 Feb. 2021.

  2. Padovani, C.R.

    1. Godoy, I. et al "Cytokines and dietary energy restriction in stable chronic obstructive pulmonary disease patients." European Respiratory Journal 22.6 (2003): 920-925. Web. 28 Feb. 2021.

  3. Paiva, S.A.R

    1. Godoy, I. et al "Cytokines and dietary energy restriction in stable chronic obstructive pulmonary disease patients." European Respiratory Journal 22.6 (2003): 920-925. Web. 28 Feb. 2021.

  4. Pajewski, T.N.

    1. Vaughan, J. et al "Exhaled breath condensate pH is a robust and reproducible assay of airway acidity." European Respiratory Journal 22.6 (2003): 889-894. Web. 28 Feb. 2021.

  5. Paraskakis, E.

    1. Paraskakis, E. et al "Microsatellite DNA instability and loss of heterozygosity in bronchial asthma." European Respiratory Journal 22.6 (2003): 951-955. Web. 28 Feb. 2021.

  6. Passam, F.

    1. Paraskakis, E. et al "Microsatellite DNA instability and loss of heterozygosity in bronchial asthma." European Respiratory Journal 22.6 (2003): 951-955. Web. 28 Feb. 2021.

  7. Patel, I.S.

    1. Donaldson, G.C. et al "Longitudinal changes in the nature, severity and frequency of COPD exacerbations." European Respiratory Journal 22.6 (2003): 931-936. Web. 28 Feb. 2021.

  8. Peiser, C.

    1. Groneberg, D.A. et al "Aspirin-sensitive rhinitis-associated changes in upper airway innervation." European Respiratory Journal 22.6 (2003): 986-991. Web. 28 Feb. 2021.

  9. Penzel, T.

    1. Penzel, T.. "Is heart rate variability the simple solution to diagnose sleep apnoea?." European Respiratory Journal 22.6 (2003): 870-971. Web. 28 Feb. 2021.

  10. Peterson, S.

    1. Calverley, P.M. et al "Maintenance therapy with budesonide and formoterol in chronicobstructive pulmonary disease." European Respiratory Journal 22.6 (2003): 912-919. Web. 28 Feb. 2021.

  11. Pichot, V.

    1. Roche, F. et al "Predicting sleep apnoea syndrome from heart period: a time-frequency wavelet analysis." European Respiratory Journal 22.6 (2003): 937-942. Web. 28 Feb. 2021.

  12. Prasse, A.

    1. Prasse, A. et al "Does interferon‐γ improve pulmonary function in idiopathic pulmonary fibrosis?." European Respiratory Journal 22.6 (2003): 906-911. Web. 28 Feb. 2021.

  13. Puig de la Bellacasa, J.

    1. Ioanas, M. et al "Hospital-acquired pneumonia: coverage and treatment adequacy of current guidelines." European Respiratory Journal 22.6 (2003): 876-882. Web. 28 Feb. 2021.

Q

  1. Quagliato, R.

    1. Fornazim, M.C. et al "Evaluation of bronchoalveolar cells in pulmonary paracoccidioidomycosis." European Respiratory Journal 22.6 (2003): 895-899. Web. 28 Feb. 2021.

R

  1. Rabe, K.F.

    1. Rabe, K.F.. "Combination therapy for chronic obstructive pulmonary disease: one size fits all?." European Respiratory Journal 22.6 (2003): 874-875. Web. 28 Feb. 2021.

  2. Richter, K.

    1. Zühlke, I.E. et al "Montelukast attenuates the airway response to hypertonic saline in moderate-to-severe COPD." European Respiratory Journal 22.6 (2003): 926-930. Web. 28 Feb. 2021.

  3. Roche, F.

    1. Roche, F. et al "Predicting sleep apnoea syndrome from heart period: a time-frequency wavelet analysis." European Respiratory Journal 22.6 (2003): 937-942. Web. 28 Feb. 2021.

  4. Ruíz, A.

    1. Mata, M. et al "Oral N‐acetylcysteine reduces bleomycin-induced lung damage and mucin Muc5ac expression in rats." European Respiratory Journal 22.6 (2003): 900-905. Web. 28 Feb. 2021.

S

  1. Santangelo, F.

    1. Mata, M. et al "Oral N‐acetylcysteine reduces bleomycin-induced lung damage and mucin Muc5ac expression in rats." European Respiratory Journal 22.6 (2003): 900-905. Web. 28 Feb. 2021.

  2. Seebus, E.

    1. Seebus, E. et al "A 71‐yr-old male with increasing dyspnoea, cough and an intrathoracic mass." European Respiratory Journal 22.6 (2003): 1042-1045. Web. 28 Feb. 2021.

  3. Seemungal, T.A.R.

    1. Donaldson, G.C. et al "Longitudinal changes in the nature, severity and frequency of COPD exacerbations." European Respiratory Journal 22.6 (2003): 931-936. Web. 28 Feb. 2021.

  4. Serrano-Mollar, A.

    1. Mata, M. et al "Oral N‐acetylcysteine reduces bleomycin-induced lung damage and mucin Muc5ac expression in rats." European Respiratory Journal 22.6 (2003): 900-905. Web. 28 Feb. 2021.

  5. Sforza, E.

    1. Roche, F. et al "Predicting sleep apnoea syndrome from heart period: a time-frequency wavelet analysis." European Respiratory Journal 22.6 (2003): 937-942. Web. 28 Feb. 2021.

  6. Siafakas, N.M.

    1. Paraskakis, E. et al "Microsatellite DNA instability and loss of heterozygosity in bronchial asthma." European Respiratory Journal 22.6 (2003): 951-955. Web. 28 Feb. 2021.

  7. Sibille, Y.

    1. Loddenkemper, R., G.J. Gibson, and Y. Sibille. "The burden of lung disease in Europe: why a European White Book on lung disease?." European Respiratory Journal 22.6 (2003): 869-69. Web. 28 Feb. 2021.

  8. Smith, A.

    1. Vaughan, J. et al "Exhaled breath condensate pH is a robust and reproducible assay of airway acidity." European Respiratory Journal 22.6 (2003): 889-894. Web. 28 Feb. 2021.

  9. Sourvinos, G.

    1. Paraskakis, E. et al "Microsatellite DNA instability and loss of heterozygosity in bronchial asthma." European Respiratory Journal 22.6 (2003): 951-955. Web. 28 Feb. 2021.

  10. Spandidos, D.

    1. Paraskakis, E. et al "Microsatellite DNA instability and loss of heterozygosity in bronchial asthma." European Respiratory Journal 22.6 (2003): 951-955. Web. 28 Feb. 2021.

  11. Svensson, M.

    1. Blomberg, A. et al "Clara cell protein as a biomarker for ozone-induced lung injury in humans." European Respiratory Journal 22.6 (2003): 883-888. Web. 28 Feb. 2021.

T

  1. Taylor, P.

    1. Cullinan, P. et al "Can early infection explain the sibling effect in adult atopy?." European Respiratory Journal 22.6 (2003): 956-961. Web. 28 Feb. 2021.

  2. Thai Dinh, Q.

    1. Groneberg, D.A. et al "Aspirin-sensitive rhinitis-associated changes in upper airway innervation." European Respiratory Journal 22.6 (2003): 986-991. Web. 28 Feb. 2021.

  3. Thomasson, L.

    1. Blomberg, A. et al "Clara cell protein as a biomarker for ozone-induced lung injury in humans." European Respiratory Journal 22.6 (2003): 883-888. Web. 28 Feb. 2021.

  4. Torres, A.

    1. Ioanas, M. et al "Hospital-acquired pneumonia: coverage and treatment adequacy of current guidelines." European Respiratory Journal 22.6 (2003): 876-882. Web. 28 Feb. 2021.

  5. Turner, R.

    1. Vaughan, J. et al "Exhaled breath condensate pH is a robust and reproducible assay of airway acidity." European Respiratory Journal 22.6 (2003): 889-894. Web. 28 Feb. 2021.

  6. Tzanakis, N.

    1. Paraskakis, E. et al "Microsatellite DNA instability and loss of heterozygosity in bronchial asthma." European Respiratory Journal 22.6 (2003): 951-955. Web. 28 Feb. 2021.

  7. Tzortzaki, E.G.

    1. Paraskakis, E. et al "Microsatellite DNA instability and loss of heterozygosity in bronchial asthma." European Respiratory Journal 22.6 (2003): 951-955. Web. 28 Feb. 2021.

U

  1. Urban, P.

    1. Vaughan, J. et al "Exhaled breath condensate pH is a robust and reproducible assay of airway acidity." European Respiratory Journal 22.6 (2003): 889-894. Web. 28 Feb. 2021.

V

  1. Valencia, M.

    1. Ioanas, M. et al "Hospital-acquired pneumonia: coverage and treatment adequacy of current guidelines." European Respiratory Journal 22.6 (2003): 876-882. Web. 28 Feb. 2021.

  2. van Aalderen, W.M.C.

    1. Dahlem, P. et al "Incidence and short-term outcome of acute lung injury in mechanically ventilated children." European Respiratory Journal 22.6 (2003): 980-985. Web. 28 Feb. 2021.

  3. van der Kooi, E.L.

    1. Wohlgemuth, M. et al "Face mask spirometry and respiratory pressures in normal subjects." European Respiratory Journal 22.6 (2003): 1001-1006. Web. 28 Feb. 2021.

  4. van der Wouden, J.C.

    1. Bernsen, R.M.D., J.C. de Jongste, and J.C. van der Wouden. "Lower risk of atopic disorders in whole cell pertussis-vaccinated children." European Respiratory Journal 22.6 (2003): 962-964. Web. 28 Feb. 2021.

  5. Vaughan, J.

    1. Vaughan, J. et al "Exhaled breath condensate pH is a robust and reproducible assay of airway acidity." European Respiratory Journal 22.6 (2003): 889-894. Web. 28 Feb. 2021.

  6. Virchow, J.C.

    1. Prasse, A. et al "Does interferon‐γ improve pulmonary function in idiopathic pulmonary fibrosis?." European Respiratory Journal 22.6 (2003): 906-911. Web. 28 Feb. 2021.

  7. Vrugt, B.

    1. Seebus, E. et al "A 71‐yr-old male with increasing dyspnoea, cough and an intrathoracic mass." European Respiratory Journal 22.6 (2003): 1042-1045. Web. 28 Feb. 2021.

W

  1. Wedzicha, J.A.

    1. Donaldson, G.C. et al "Longitudinal changes in the nature, severity and frequency of COPD exacerbations." European Respiratory Journal 22.6 (2003): 931-936. Web. 28 Feb. 2021.

  2. Welker, P.

    1. Groneberg, D.A. et al "Aspirin-sensitive rhinitis-associated changes in upper airway innervation." European Respiratory Journal 22.6 (2003): 986-991. Web. 28 Feb. 2021.

  3. White, C.W.

    1. Cullinan, P. et al "Can early infection explain the sibling effect in adult atopy?." European Respiratory Journal 22.6 (2003): 956-961. Web. 28 Feb. 2021.

  4. Wilkinson, T.M.A.

    1. Donaldson, G.C. et al "Longitudinal changes in the nature, severity and frequency of COPD exacerbations." European Respiratory Journal 22.6 (2003): 931-936. Web. 28 Feb. 2021.

  5. Witt, C.

    1. Dingli, K. et al "Spectral oscillations of RR intervals in sleep apnoea/hypopnoea syndrome patients." European Respiratory Journal 22.6 (2003): 943-950. Web. 28 Feb. 2021.
    2. Groneberg, D.A. et al "Aspirin-sensitive rhinitis-associated changes in upper airway innervation." European Respiratory Journal 22.6 (2003): 986-991. Web. 28 Feb. 2021.

  6. Wohlgemuth, M.

    1. Wohlgemuth, M. et al "Face mask spirometry and respiratory pressures in normal subjects." European Respiratory Journal 22.6 (2003): 1001-1006. Web. 28 Feb. 2021.

  7. Wraith, P.K.

    1. Dingli, K. et al "Spectral oscillations of RR intervals in sleep apnoea/hypopnoea syndrome patients." European Respiratory Journal 22.6 (2003): 943-950. Web. 28 Feb. 2021.

Z

  1. Zervou, M.

    1. Paraskakis, E. et al "Microsatellite DNA instability and loss of heterozygosity in bronchial asthma." European Respiratory Journal 22.6 (2003): 951-955. Web. 28 Feb. 2021.

  2. Zhong, N.

    1. Calverley, P.M. et al "Maintenance therapy with budesonide and formoterol in chronicobstructive pulmonary disease." European Respiratory Journal 22.6 (2003): 912-919. Web. 28 Feb. 2021.

  3. Zhu, J.

    1. Gamble, E. et al "Variation of CD8+ T‐lymphocytes around the bronchial internal perimeter in chronic bronchitis." European Respiratory Journal 22.6 (2003): 992-995. Web. 28 Feb. 2021.

  4. Zühlke, I.E.

    1. Zühlke, I.E. et al "Montelukast attenuates the airway response to hypertonic saline in moderate-to-severe COPD." European Respiratory Journal 22.6 (2003): 926-930. Web. 28 Feb. 2021.

  5. Zweng, M.

    1. Groneberg, D.A. et al "Aspirin-sensitive rhinitis-associated changes in upper airway innervation." European Respiratory Journal 22.6 (2003): 986-991. Web. 28 Feb. 2021.
Back to top

Search Within This Issue

Jump to

Manage Table of content Alerts